(Q45448545)

14 December 2017

Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study (English)

1 reference

14 December 2017

1 reference

1 reference

3

1 reference

14 December 2017

6

1 reference

14 December 2017

12

1 reference

14 December 2017

A Tjonneland

7

0 references

Kim Overvad

8

object named as

K Overvad

1 reference

14 December 2017

5

H Boeing

1 reference

14 December 2017

9

R Kaaks

1 reference

14 December 2017

S S M Chan

1

1 reference

14 December 2017

S S M Chan

2

1 reference

14 December 2017

M M Bergmann

4

1 reference

14 December 2017

H Kennedy

10

1 reference

14 December 2017

K-T Khaw

11

1 reference

14 December 2017

A R Hart

13

1 reference

14 December 2017

language of work or name

English

0 references

publication date

26 July 2011

1 reference

Alimentary Pharmacology & Therapeutics

14 December 2017

1 reference

14 December 2017

34

1 reference

14 December 2017

6

1 reference

14 December 2017

649-655

1 reference

Quality of life of patients with ulcerative colitis: past, present, and future

14 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Review article: colorectal carcinoma and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Epidemiology and natural history of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Determinants of the short-term gastric damage caused by NSAIDs in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Lipid mediator class switching during acute inflammation: signals in resolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

In vitro effects of eicosanoids derived from different 20-carbon Fatty acids on production of monocyte-derived cytokines in human whole blood cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Novel mechanism of vasodilation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

A meta-analysis of the role of smoking in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Prostaglandin E2 inhibits production of the inflammatory chemokines CCL3 and CCL4 in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

Acquired microvascular dysfunction in inflammatory bowel disease: Loss of nitric oxide-mediated vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04784.X

10.1111/J.1365-2036.2011.04784.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference